BioAge Net Working Capital vs Common Stock Analysis

BIOA Stock

19.14 0.70 3.80%

BioAge Labs, financial indicator trend analysis is way more than just evaluating BioAge Labs, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioAge Labs, is a good investment. Please check the relationship between BioAge Labs, Net Working Capital and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.

Net Working Capital vs Common Stock

Net Working Capital vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioAge Labs, Net Working Capital account and Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between BioAge Labs,'s Net Working Capital and Common Stock is -0.24. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Common Stock in the same time period over historical financial statements of BioAge Labs,, assuming nothing else is changed. The correlation between historical values of BioAge Labs,'s Net Working Capital and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of BioAge Labs, are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Working Capital i.e., BioAge Labs,'s Net Working Capital and Common Stock go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Working Capital

Common Stock

Most indicators from BioAge Labs,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioAge Labs, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.As of November 24, 2024, Selling General Administrative is expected to decline to about 9.2 M. In addition to that, Sales General And Administrative To Revenue is expected to decline to 0.76

	2023	2024 (projected)
Interest Expense	7.8M	5.7M
Depreciation And Amortization	162K	153.9K

Interest Expense Depreciation And Amortization

BioAge Labs, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.63	0.56	0.32	0.92	0.78	-0.65	-0.04	-0.17	0.26	0.37	0.8	0.86	0.37	-0.94	0.51	-0.61	-0.92	-0.74	0.69	0.83	-0.64	0.46	-0.11	0.42	-0.82
Short Long Term Debt Total	0.63		0.37	0.86	0.46	0.61	-0.37	0.5	-0.59	0.27	0.02	0.62	0.59	0.02	-0.45	-0.08	0.02	-0.58	-0.34	0.59	0.66	-0.26	0.14	0.6	0.58	-0.42
Other Current Liab	0.56	0.37		0.4	0.4	0.18	-0.7	-0.32	0.38	-0.47	0.61	0.2	0.21	0.61	-0.64	0.28	-0.58	-0.37	-0.45	0.75	0.12	-0.16	0.63	0.16	0.09	-0.62
Total Current Liabilities	0.32	0.86	0.4		0.03	0.41	-0.15	0.59	-0.39	0.22	-0.15	0.41	0.33	-0.15	-0.16	-0.38	0.14	-0.15	-0.05	0.44	0.22	0.22	-0.07	0.82	0.66	-0.15
Total Stockholder Equity	0.92	0.46	0.4	0.03		0.57	-0.72	-0.27	-0.11	0.13	0.53	0.6	0.72	0.53	-0.93	0.75	-0.61	-0.99	-0.74	0.66	0.87	-0.86	0.61	-0.34	0.13	-0.81
Property Plant And Equipment Net	0.78	0.61	0.18	0.41	0.57		-0.07	0.51	-0.54	0.7	-0.29	1.0	0.92	-0.29	-0.55	0.02	-0.18	-0.59	-0.38	0.22	0.75	-0.22	-0.2	0.03	0.72	-0.37
Current Deferred Revenue	-0.65	-0.37	-0.7	-0.15	-0.72	-0.07		0.52	-0.27	0.43	-0.86	-0.1	-0.21	-0.86	0.78	-0.66	0.62	0.71	0.62	-0.94	-0.43	0.72	-0.92	0.0	0.02	0.85
Net Debt	-0.04	0.5	-0.32	0.59	-0.27	0.51	0.52		-0.82	0.64	-0.83	0.48	0.28	-0.83	0.35	-0.77	0.64	0.17	0.31	-0.27	0.19	0.38	-0.76	0.62	0.7	0.35
Retained Earnings	-0.17	-0.59	0.38	-0.39	-0.11	-0.54	-0.27	-0.82		-0.54	0.6	-0.53	-0.37	0.6	-0.14	0.41	-0.62	0.23	-0.16	0.09	-0.59	0.11	0.49	-0.36	-0.44	-0.16
Accounts Payable	0.26	0.27	-0.47	0.22	0.13	0.7	0.43	0.64	-0.54		-0.64	0.69	0.67	-0.64	-0.06	-0.21	0.1	-0.16	-0.08	-0.3	0.4	0.06	-0.6	0.04	0.71	0.07
Cash	0.37	0.02	0.61	-0.15	0.53	-0.29	-0.86	-0.83	0.6	-0.64		-0.25	-0.03	1.0	-0.63	0.73	-0.72	-0.49	-0.61	0.69	0.12	-0.61	0.99	-0.23	-0.41	-0.71
Non Current Assets Total	0.8	0.62	0.2	0.41	0.6	1.0	-0.1	0.48	-0.53	0.69	-0.25		0.93	-0.25	-0.58	0.06	-0.21	-0.62	-0.41	0.25	0.77	-0.26	-0.16	0.02	0.71	-0.4
Non Currrent Assets Other	0.86	0.59	0.21	0.33	0.72	0.92	-0.21	0.28	-0.37	0.67	-0.03	0.93		-0.03	-0.73	0.23	-0.45	-0.73	-0.66	0.28	0.78	-0.41	0.04	-0.07	0.64	-0.58
Cash And Short Term Investments	0.37	0.02	0.61	-0.15	0.53	-0.29	-0.86	-0.83	0.6	-0.64	1.0	-0.25	-0.03		-0.63	0.73	-0.72	-0.49	-0.61	0.69	0.12	-0.61	0.99	-0.23	-0.41	-0.71
Net Receivables	-0.94	-0.45	-0.64	-0.16	-0.93	-0.55	0.78	0.35	-0.14	-0.06	-0.63	-0.58	-0.73	-0.63		-0.71	0.81	0.9	0.82	-0.74	-0.68	0.69	-0.69	0.24	-0.22	0.9
Good Will	0.51	-0.08	0.28	-0.38	0.75	0.02	-0.66	-0.77	0.41	-0.21	0.73	0.06	0.23	0.73	-0.71		-0.65	-0.68	-0.45	0.49	0.41	-0.68	0.74	-0.69	-0.39	-0.54
Common Stock Shares Outstanding	-0.61	0.02	-0.58	0.14	-0.61	-0.18	0.62	0.64	-0.62	0.1	-0.72	-0.21	-0.45	-0.72	0.81	-0.65		0.52	0.83	-0.47	-0.18	0.47	-0.69	0.37	-0.03	0.8
Non Current Liabilities Total	-0.92	-0.58	-0.37	-0.15	-0.99	-0.59	0.71	0.17	0.23	-0.16	-0.49	-0.62	-0.73	-0.49	0.9	-0.68	0.52		0.72	-0.69	-0.91	0.85	-0.58	0.21	-0.19	0.8
Inventory	-0.74	-0.34	-0.45	-0.05	-0.74	-0.38	0.62	0.31	-0.16	-0.08	-0.61	-0.41	-0.66	-0.61	0.82	-0.45	0.83	0.72		-0.5	-0.51	0.71	-0.63	0.11	-0.23	0.93
Other Current Assets	0.69	0.59	0.75	0.44	0.66	0.22	-0.94	-0.27	0.09	-0.3	0.69	0.25	0.28	0.69	-0.74	0.49	-0.47	-0.69	-0.5		0.48	-0.56	0.77	0.22	0.19	-0.77
Other Stockholder Equity	0.83	0.66	0.12	0.22	0.87	0.75	-0.43	0.19	-0.59	0.4	0.12	0.77	0.78	0.12	-0.68	0.41	-0.18	-0.91	-0.51	0.48		-0.73	0.23	-0.11	0.33	-0.56
Total Liab	-0.64	-0.26	-0.16	0.22	-0.86	-0.22	0.72	0.38	0.11	0.06	-0.61	-0.26	-0.41	-0.61	0.69	-0.68	0.47	0.85	0.71	-0.56	-0.73		-0.68	0.31	0.08	0.77
Total Current Assets	0.46	0.14	0.63	-0.07	0.61	-0.2	-0.92	-0.76	0.49	-0.6	0.99	-0.16	0.04	0.99	-0.69	0.74	-0.69	-0.58	-0.63	0.77	0.23	-0.68		-0.18	-0.34	-0.76
Short Term Debt	-0.11	0.6	0.16	0.82	-0.34	0.03	0.0	0.62	-0.36	0.04	-0.23	0.02	-0.07	-0.23	0.24	-0.69	0.37	0.21	0.11	0.22	-0.11	0.31	-0.18		0.55	0.03
Intangible Assets	0.42	0.58	0.09	0.66	0.13	0.72	0.02	0.7	-0.44	0.71	-0.41	0.71	0.64	-0.41	-0.22	-0.39	-0.03	-0.19	-0.23	0.19	0.33	0.08	-0.34	0.55		-0.25
Common Stock	-0.82	-0.42	-0.62	-0.15	-0.81	-0.37	0.85	0.35	-0.16	0.07	-0.71	-0.4	-0.58	-0.71	0.9	-0.54	0.8	0.8	0.93	-0.77	-0.56	0.77	-0.76	0.03	-0.25

Click cells to compare fundamentals

BioAge Labs, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether BioAge Labs, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs, Stock:

How To Invest In BioAge

Details

Is BioAge Stock a good investment?

Details

What is BioAge Labs,'s Net Worth?

Details

Largest Pharmaceutical Products Companies

View

Largest Drug Manufacturers - Specialty & Generic Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.40)

The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioAge Net Working Capital vs Common Stock Analysis

Net Working Capital vs Common Stock

Net Working Capital vs Common Stock Correlation Analysis

Correlation Coefficient

Net Working Capital

Common Stock

BioAge Labs, fundamental ratios Correlations

BioAge Labs, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Non Currrent Assets Other	+ 0.93	Non Current Assets Total
Common Stock	+ 0.93	Inventory

Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Other Current Assets	- 0.94	Current Deferred Revenue
Net Receivables	- 0.94	Total Assets
Net Receivables	- 0.93	Total Stockholder Equity
Total Current Assets	- 0.92	Current Deferred Revenue
Non Current Liabilities Total	- 0.92	Total Assets